NeuroMetrix to Present at the LD Micro Invitational Conference on June 7, 2016

WALTHAM, Mass.–(BUSINESS WIRE)–$NURO #chronicpain–NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani
M.D., Ph.D., President and Chief Executive Officer, is scheduled to
speak at the upcoming LD Micro Invitational at the Luxe Sunset Bel Air
Hotel in Los Angeles, CA. Dr. Gozani intends to provide an update on the
Company’s business activities including the Quell® Wearable
Pain Relief device.

NeuroMetrix’s presentation is scheduled for Tuesday, June 7, 2016, at
10:00 a.m. Pacific Time (1:00 p.m. Eastern). A live audio webcast will
be available on the investor relations section of the corporate website
This webcast will be archived after the live event.

About Quell

Quell utilizes NeuroMetrix’s patented neurostimulation technology to
provide widespread relief from chronic pain. The advanced wearable
device is lightweight and can be worn during the day while active, and
at night while sleeping. It has been cleared by the FDA for treatment of
chronic pain without a prescription. In a recent study, 81% of Quell
users reported an improvement in their chronic pain. Quell was recently
named “Winner” in the Wearable Tech category at the SXSW Interactive
Innovation Awards. It is available for purchase at,
selected retailers and healthcare professionals.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an
independent resource in the microcap space. What started out as a
newsletter highlighting unique companies has transformed into an event
platform hosting several influential conferences annually (Invitational,
Summit, and Main Event). In 2015, LDM launched the first pure microcap
index (the LDMi) to exclusively provide intraday information on the
entire sector. For more information, visit

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. For more information, please visit


NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer